Prescription drug marketing comes under debate
Organisations representing patients, medical professionals and consumers are calling on the European Commission to rethink proposals to allow drug companies to provide information direct to consumers.
Register now for free to view this page
Please register now to access this content
This content is for registered users only
To check that you are registered please enter your email address below
Not registered?
Registration is simple and quick. By registering you will be able to read selected articles on HSJ.co.uk, PLUS sign up to HSJ email newsletters straight away.
